Expression and Folding of Recombinant Bovine Prethrombin-2 and Its Activation to Thrombin (*)

Bovine prethrombin-2 has been produced in Escherichia coli using a T7 expression system. The expressed prethrombin-2 formed intracellular inclusion bodies which were solubilized by reversible sulfonation of the cysteines in the presence of 7 M guanidine hydrochloride. Sulfonated prethrombin-2 was refolded in the presence of 4 M guanidine hydrochloride, using oxidized and reduced glutathione as the redox couple. The folded protein was purified by heparin affinity chromatography and activated to thrombin with Echis carinatus snake venom. The resulting thrombin was also purified by heparin affinity chromatography. Kinetic constants were determined for the hydrolysis of H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroaniline by recombinant thrombin (k = 123 ± 10 s and K = 2.91 ± 0.3 μM). These values are in good agreement with those determined for wild-type thrombin (k = 97 ± 8 s and K = 2.71 ± 0.25 μM). From the thrombin-mediated release of fibrinopeptide A from fibrinogen, k/Kwas found to be the same for recombinant (17.3 ± 1.2 μM s) and wild-type (16.7 ± 2.0 μM s) thrombin. These results, taken together with circular dichroism spectra and the elution position of prethrombin-2 from a heparin affinity resin, indicate that prethrombin-2 was folded into a conformation similar to that of the wild-type protein. In addition, since E. coli produces deglycosylated enzymes, these findings suggest that the carbohydrate on the B chain of wild-type thrombin does not affect the amidolytic and fibrinolytic activities of thrombin. Finally, this expression system can be used to prepare mutants of prethrombin-2 for future structure-function studies involving thrombin and its substrates; some preliminary results of this type are presented here.

[1]  H. Scheraga,et al.  The Fibrinogen-Fibrin Conversion1 , 1957 .

[2]  L. Lorand,et al.  ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN. , 1964, Archives of biochemistry and biophysics.

[3]  H. Scheraga,et al.  TITRATION BEHAVIOR OF BOVINE THROMBIN. , 1964, Archives of biochemistry and biophysics.

[4]  P. R. Bevington,et al.  Data Reduction and Error Analysis for the Physical Sciences , 1969 .

[5]  B. S. Hartley,et al.  10 Pancreatic Elastase , 1971 .

[6]  R. Doolittle,et al.  Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. , 1974, Biochemistry.

[7]  C. Esmon,et al.  A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions. , 1974, The Journal of biological chemistry.

[8]  N. K. Sinha,et al.  Refolding of reduced, denatured trypsinogen and trypsin immobilized on Agarose beads. , 1975, The Journal of biological chemistry.

[9]  H. Scheraga,et al.  Mechanism of action of thrombin on fibrinogen. On the role of the A chain of bovine thrombin in specificity and in differentiating between thrombin and trypsin. , 1975, Archives of biochemistry and biophysics.

[10]  A. Light,et al.  Refolding of the mixed disulfide of bovine trypsinogen and glutathione. , 1979, The Journal of biological chemistry.

[11]  Refolding of bovine trypsinogen with one and two disulfide bonds reduced and carboxymethylated. , 1979, The Journal of biological chemistry.

[12]  K. Mann,et al.  Thrombin-catalyzed activation of single chain bovine factor V. , 1979, The Journal of biological chemistry.

[13]  H. Scheraga,et al.  Assay of bovine fibrinopeptides by high performance liquid chromatography. , 1979, Analytical biochemistry.

[14]  Stability differences between high coagulant (alpha) and noncoagulant (gamma) human thrombins. Denaturation. , 1980, The Journal of biological chemistry.

[15]  D. Bing,et al.  (p-Amidinophenyl)methanesulfonyl fluoride, an irreversible inhibitor of serine proteases. , 1980, Biochemistry.

[16]  L. Hoyer,et al.  The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation. , 1981, The Journal of laboratory and clinical medicine.

[17]  H. Scheraga,et al.  Mechanism of action of thrombin on fibrinogen. Direct evidence for the involvement of phenylalanine at position P9. , 1982, Biochemistry.

[18]  Refolding of bovine threonine-neochymotrypsinogen. , 1982, The Journal of biological chemistry.

[19]  C. Esmon,et al.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. , 1982, The Journal of biological chemistry.

[20]  C. Jackson,et al.  Solution composition dependent variation in extinction coefficients for p-nitroaniline. , 1983, Biochimica et biophysica acta.

[21]  J. Shafer,et al.  A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit. , 1984, Thrombosis research.

[22]  H. Scheraga,et al.  Folding of ribonuclease A from a partially disordered conformation: kinetic study under transition conditions , 1982 .

[23]  H A Scheraga,et al.  Sensitive quantitative analysis of disulfide bonds in polypeptides and proteins. , 1984, Analytical biochemistry.

[24]  R. MacGillivray,et al.  Characterization of bovine prothrombin mRNA and its translation product. , 1984, Biochemistry.

[25]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[26]  E. Davie.  Introduction to the blood coagulation cascade and cloning of blood coagulation factors , 1986 .

[27]  H. Scheraga.  Chemical Basis of Thrombin Interactions with Fibrinogen a , 1986, Annals of the New York Academy of Sciences.

[28]  B. Blombäck,et al.  Specificity of Thrombin and Its Action on Fibrinogen , 1986, Annals of the New York Academy of Sciences.

[29]  A. Cantor,et al.  Expression of completely gamma-carboxylated recombinant human prothrombin. , 1987, The Journal of biological chemistry.

[30]  K. Mann,et al.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.

[31]  H. Scheraga,et al.  Structural studies of a folding intermediate of bovine pancreatic ribonuclease A by continuous recycled flow. , 1988, Biochemistry.

[32]  Robert Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989 .

[33]  H. Scheraga,et al.  High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen. , 1989, Biochemistry.

[34]  H. Scheraga,et al.  High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen. , 1989, Biochemistry.

[35]  H. Scheraga,et al.  High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen. , 1989, Biochemistry.

[36]  D. Goeddel.  Systems for heterologous gene expression. , 1990, Methods in enzymology.

[37]  C. Esmon,et al.  Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues. , 1991, The Journal of biological chemistry.

[38]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[39]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[40]  J. Shafer,et al.  Reconstitution of catalytically competent human zeta-thrombin by combination of zeta-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to zeta-thrombin residues B149-259. , 1991, Biochemistry.

[41]  J. Sheehan,et al.  Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Expression, isolation, and characterization of an active site (serine 528----alanine) mutant of recombinant bovine prothrombin. , 1991, The Journal of biological chemistry.

[43]  H. Scheraga,et al.  Nuclear Magnetic Resonance Studies of Thrombin-Fibrinopeptide and Thrombin-Hirudin Complexes , 1992 .

[44]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[45]  C. Esmon,et al.  Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin and protein C. Structural link between the autolysis loop and the Tyr-Pro-Pro-Trp insertion of thrombin. , 1992, The Journal of biological chemistry.

[46]  R. Huber,et al.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. , 1994, The Journal of biological chemistry.

[47]  H. Scheraga,et al.  Expression of wild-type and mutant bovine pancreatic ribonuclease A in Escherichia coli. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Y. Li,et al.  Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. , 1994, The Journal of biological chemistry.

[49]  D. Banfield,et al.  Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A). , 1994, The Journal of biological chemistry.

[50]  M. Aiach,et al.  Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. , 1994, The Journal of biological chemistry.